ISR Immune System Regulation Holding AB (publ) (ISR.ST)

STO Healthcare Biotechnology

ISR Immune System Regulation Holding AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Stockholm, SE. The stock last traded at $1.40, up 0.00% on the session, giving a market capitalisation of $96.6M. Its beta of 0.44 implies it has historically moved less than the broad market.

ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm, Sweden, is dedicated to the discovery and development of pharmaceutical solutions for viral infections. Its current therapeutic pipeline features a Covid-19 vaccine candidate, treatments for Hepatitis B (HBV) and HIV, and an oncology program.

ISR Immune System Regulation Holding AB (publ) is most often compared with the following Healthcare names: